Author's posts
Montefiore Health scores $1.2 billion financing deal that will add $600 million to flagship hospital’s balance sheet
The financing package is a hybrid of taxable and nontaxable bonds that will, among other things, reimburse the system for more than $350 million in capital projects.
UnitedHealthcare is evaluating options after losing lawsuit over risk adjustment payments
UnitedHealthcare and Oxford Health Insurance contended the payments to New York were an unconstitutional taking of their property.
DOJ, HHS continue war on Medicare fraud with formation of new regional fraud strike force
Prosecutors for the 10 regional strike forces currently in operation have charged over 3,700 defendants in connection to more than $14 billion in false billings, DOJ says.
Mayo Clinic comes out on top as U.S. News and World Report unveils 2018-19 Best Hospitals
More than 1,100 hospitals were rated high performing in at least one common procedure or condition.
Moody’s: CMS proposed changes to Medicare’s outpatient prospective payment system could hurt hospitals
Site-neutral clinic payments, 340B drug program policy, adding procedures to covered list for ambulatory surgery centers, all hit hospital margins.
Healthcare analytics market to grow and hit $31 billion by 2022
Analytics enable providers to make decisions based on vast amounts of data, resulting in savings.
Hospital profits in Massachusetts shriveling due to financial pressure
Employers drive healthcare change through direct contracting, ACOs, combatting opioid epidemic
From direct contracting between employers and providers to campaigns aimed at reducing the stigma around mental health issues, employers are doing it for themselves.
Humana completes sale of long-term care insurance policy business KMG, at a loss of $790 million
Insurer is investing in at-home and hospice organizations and is focusing on senior primary care through Walgreens partnership.
HHS Secretary Alex Azar warns drug makers to pay full Medicaid rebate amount
Some drug companies pay less than what they would otherwise owe by introducing a new drug formulation, HHS Secretary Alex Azar says.
